Literature DB >> 36149445

IL13 and periostin in active fibrogenic areas of the extrahepatic bile ducts in biliary atresia patients.

Yuki Sengoku1, Mayumi Higashi2, Kazuya Nagayabu1, Shohei Takayama1, Shigehisa Fumino1, Shigeyoshi Aoi1, Taizo Furukawa1, Tatsuro Tajiri1.   

Abstract

BACKGROUND: The leading pathology of biliary atresia (BA) is inflammatory and fibrous obstruction of extrahepatic bile duct, but the pathogenesis remains unclear. IL13 is a cytokine associated with allergies and inflammatory fibrosis, and periostin induces fibrogenesis by stimulation with IL13. We analyzed the involvement of IL13 and periostin in inflammatory fibrosis in the extrahepatic bile duct of BA patients.
MATERIALS AND METHODS: Surgically resected tissues from the hepatic hilar area of BA patients were immunostained with CD45, α-SMA, IL13 and periostin and statistically analyzed. Fibroblasts from the resected tissue were cultured with recombinant IL13, and periostin production was analyzed by quantitative polymerase chain reaction and Western blotting.
RESULTS: IL13 was stained in 93% of large and micro bile ducts, and 92.1% matched with the CD45 location (p = 0.006) around the large bile ducts. Periostin staining correlated with the localization of IL13 and αSMA (p < 0.001) around the large bile ducts. Periostin mRNA and protein were upregulated by IL13 stimulation in cultured fibroblasts.
CONCLUSION: IL13 was associated with induced periostin expression by fibroblasts, playing a vital role in the pathogenesis of fibrogenesis around the extrahepatic bile duct in BA.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Biliary atresia; Fibrogenesis; IL13; Inflammation; Periostin

Year:  2022        PMID: 36149445     DOI: 10.1007/s00383-022-05238-4

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   2.003


  24 in total

1.  Bile duct size does not predict success of portoenterostomy for biliary atresia.

Authors:  S E Langenburg; J Poulik; M Goretsky; A A Klein; M D Klein
Journal:  J Pediatr Surg       Date:  2000-06       Impact factor: 2.545

Review 2.  Interleukin-13: A promising therapeutic target for autoimmune disease.

Authors:  Yan-Mei Mao; Chan-Na Zhao; Jing Leng; Rui-Xue Leng; Dong-Qing Ye; Song Guo Zheng; Hai-Feng Pan
Journal:  Cytokine Growth Factor Rev       Date:  2018-12-12       Impact factor: 7.638

3.  Biliary atresia liver histopathological determinants of early post-Kasai outcome.

Authors:  Anh-Hoa Pham Nguyen; Yen Hai T Pham; Giap H Vu; My Ha Nguyen; Thach Ngoc Hoang; AiXuan Holterman
Journal:  J Pediatr Surg       Date:  2021-03-26       Impact factor: 2.545

4.  Hepatic portoenterostomy for biliary atresia. A comparative study of histology and prognosis after surgery.

Authors:  D Lawrence; E R Howard; C Tzannatos; A P Mowat
Journal:  Arch Dis Child       Date:  1981-06       Impact factor: 3.791

Review 5.  Type 2 immunity in tissue repair and fibrosis.

Authors:  Richard L Gieseck; Mark S Wilson; Thomas A Wynn
Journal:  Nat Rev Immunol       Date:  2017-08-30       Impact factor: 53.106

6.  Histologic features of the portal plate in extrahepatic biliary atresia and their impact on prognosis--a Danish study.

Authors:  Qazaz Mirza; Nina Kvist; Bodil Laub Petersen
Journal:  J Pediatr Surg       Date:  2009-07       Impact factor: 2.545

7.  The Kasai portoenterostomy for biliary atresia: A review of a 27-year experience with 81 patients.

Authors:  Barbara E Wildhaber; Arnold G Coran; Robert A Drongowski; Ronald B Hirschl; James D Geiger; Joseph L Lelli; Daniel H Teitelbaum
Journal:  J Pediatr Surg       Date:  2003-10       Impact factor: 2.545

8.  Ductal remnants in extrahepatic biliary atresia: A histopathologic study with clinical correlation.

Authors:  R S Chandra; R P Altman
Journal:  J Pediatr       Date:  1978-08       Impact factor: 4.406

9.  Does the morphology of the extrahepatic biliary remnants in biliary atresia influence survival? A review of 205 cases.

Authors:  C E Tan; M Davenport; M Driver; E R Howard
Journal:  J Pediatr Surg       Date:  1994-11       Impact factor: 2.545

Review 10.  Interleukin 13 and its role in gut defence and inflammation.

Authors:  Peter Mannon; Walter Reinisch
Journal:  Gut       Date:  2012-09-01       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.